Fig. 1: miR-206 was decreased in NAFLD and overexpression of miR-206 inhibited lipogenesis and TG secretion.

A miR-206 level in HFD-fed mice and control mice. B miR-206 level in liver cells treated with FFA or control. C Representative oil-red o staining images of cells overexpressed with miR-206 following FFA or control treatment. D Secreted TG level in cells with transfection of miR-206 mimics or NC following FFA or control treatment. E Protein levels of lipogenesis-related proteins in cells with the overexpression of miR-206 mimics or NC following FFA or control treatment. F Quantifications of E. *p < 0.05, **p < 0.01, and ***p < 0.001.